LEWISVILLE, TEXAS – July 26, 2022 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a world medical gadget firm with a backbone and orthopedics focus, right now introduced the restricted market launch and first affected person implant of the Virtuos™ Lyograft, a first-of-its-kind, shelf-stable and full autograft substitute for backbone and orthopedic procedures. This allograft is ready by MTF Biologics via a proprietary course of that preserves all biologic elements obligatory for bone therapeutic inside the graft. Virtuos is offered in a room-temperature, ready-to-use, moldable kind.
“The Virtuos allograft is exclusive in the truth that it may be saved at room temperature and is able to implant inside two minutes of being hydrated,” stated Dr. Tomas Ellis, a neurosurgeon at Baylor Scott and White Surgical Hospital in Fort Value, Texas, who implanted the primary affected person. “This helps guarantee we are able to at all times have an easy-to-use, moldable, full bone graft available, and it streamlines the preparation and general surgical process time.”
“The Virtuos Lyograft offered via our unique partnership with MTF Biologics is on the forefront of allograft expertise,” stated Orthofix President of International Backbone Kevin Kenny. “Processed via a proprietary preservation methodology, Virtuos supplies one of the best of each worlds. It delivers a high-quality shelf-stable bone graft with the scientific efficiency and superior dealing with that clinicians need, in addition to streamlined logistics for storage and preparation for the hospital.”
Virtuos gives vital logistical and cost-savings benefits to the hospital with improved transport, storage and working room effectivity. The room temperature cargo and storage of Virtuos eliminates the usage of massive portions of dry ice, Styrofoam shippers and freezer storage, enabling versatile transport choices and lowered packaging, with the goal of a lowered carbon footprint.
The Virtuos Lyograft is a complementary addition to the great line of biologics provided by Orthofix via its unique partnership with MTF Biologics together with the Trinity Elite™, Trinity Evolution™, FiberFuse™ Superior and FiberFuse Strip allografts, AlloQuent structural allograft and the Legacy™ DBM. Along with MTF Biologic options, Orthofix proudly markets and distributes the Opus™ BA bioactive bone graft, Opus™ Mg Set bone void filler, Opus™ osteoconductive matrix and the O-Genesis™ graft supply system. This broad portfolio offers surgeons the power to pick out the most suitable choice to satisfy their procedural and affected person wants.
About Orthofix
Orthofix Medical Inc. is a world medical gadget firm with a backbone and orthopedics focus. The Firm’s mission is to ship revolutionary, quality-driven options whereas partnering with well being care professionals to enhance affected person mobility. Headquartered in Lewisville, Texas, Orthofix’s backbone and orthopedics merchandise are distributed in additional than 60 international locations by way of the Firm’s gross sales representatives and distributors. For extra data, please go to www.Orthofix.com.
About MTF Biologics
MTF Biologics is a world nonprofit group that saves and heals lives by honoring donated presents, serving sufferers and advancing science. They supply unmatched service, sources, and experience to donors and their family members who give the reward of donation, individuals who depend upon tissue and organ transplants, healthcare suppliers, and clinicians and scientists.
The Worldwide Institute for the Development of Drugs (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by offering their presents to the medical analysis neighborhood to fight and remedy illnesses. Statline, additionally a Division of MTF Biologics, supplies specialised communications and expertise experience to organ, tissue, and eye procurement organizations, in addition to the hospitals and sufferers that they serve. Its sister group, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation), expands its attain to sufferers throughout the globe. For extra data, go to www.mtfbiologics.org.
Ahead-Trying Statements
This communication incorporates forward-looking statements inside the which means of Part 21E of the Securities Trade Act of 1934, as amended, and Part 27A of the Securities Act of 1933, as amended, regarding our enterprise and monetary outlook, that are primarily based on our present beliefs, assumptions, expectations, estimates, forecasts and projections. In some circumstances, you may establish forward-looking statements by terminology akin to “could,” “will,” “ought to,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “tasks,” “intends,” “predicts,” “potential,” or “proceed” or different comparable terminology. These forward-looking statements will not be ensures of our future efficiency and contain dangers, uncertainties, estimates and assumptions which are troublesome to foretell, together with the dangers described in Half I, Merchandise 1A underneath the heading Threat Components in our Annual Report on Type 10-Ok for the 12 months ended December 31, 2021 (the “2021 Type 10-Ok”). Along with the dangers described there, elements that might trigger or contribute to such variations could embrace, however will not be restricted to: the chance that surgeons could also be sluggish to undertake the Virtuos Lyograft; the chance that future affected person research or scientific expertise and information could point out that therapy with the Virtuos Lyograft doesn’t enhance affected person outcomes as a lot as beforehand believed, or in any other case name into query the advantages of the usage of these merchandise to sufferers, hospitals and surgeons; the chance that the merchandise could not carry out as meant and should due to this fact not proceed or obtain business success; the chance that rivals could develop superior merchandise or could have a larger market place enabling extra profitable commercialization; the chance that insurance coverage payers could decline to reimburse healthcare suppliers for the usage of our merchandise.
This checklist of dangers, uncertainties and different elements is just not full. We focus on a few of these issues extra totally, in addition to sure danger elements that might have an effect on our enterprise, monetary situation, outcomes of operations, and prospects, in reviews we file from time-to-time with the SEC, which can be found to learn at www.sec.gov. All or any forward-looking statements that we make could turn into incorrect (because of inaccurate assumptions that we make or in any other case), and our precise outcomes and outcomes could differ materially from these expressed in these forward-looking statements. You shouldn’t place undue reliance on any of those forward-looking statements. Additional, any forward-looking assertion speaks solely as of the date hereof, until it’s particularly in any other case acknowledged to be made as of a unique date. We undertake no obligation to replace, and expressly disclaim any obligation to replace, our forward-looking statements, whether or not on account of circumstances or occasions that come up after the date hereof, new data, or in any other case.
Contacts
Alexa Huerta
Investor Relations
Tel 214 937 3190
alexahuerta@orthofix.com
Denise Landry
Media Relations
Tel 214 937 2529
deniselandry@orthofix.com
Discussion about this post